{"id":7895,"date":"2023-08-03T12:22:46","date_gmt":"2023-08-03T12:22:46","guid":{"rendered":"https:\/\/www.caltagmedsystems.co.uk\/information\/?p=7895"},"modified":"2023-08-03T12:22:47","modified_gmt":"2023-08-03T12:22:47","slug":"neutralising-antibody-detection-kits-for-sars-cov-2-variants","status":"publish","type":"post","link":"https:\/\/www.caltagmedsystems.co.uk\/information\/neutralising-antibody-detection-kits-for-sars-cov-2-variants\/","title":{"rendered":"Neutralising Antibody Detection Kits for SARS-CoV-2 Variants"},"content":{"rendered":"\n
Product Name<\/strong><\/td>PID<\/strong><\/td>Application\/Activity<\/strong><\/td><\/tr>
SARS-CoV-2 Neutralizing Antibodies Detection Kit (B.1.1.7 Variant, Alpha)<\/strong><\/td>AG-48B-0003<\/a><\/td>To measure the presence of neutralising\/blocking antibodies in human serum\/plasma that inhibit the binding of the SARS-CoV-2 Spike (RBD) (B.1.1.7 Variant, Alpha) protein to its human receptor ACE2.<\/td><\/tr>
SARS-CoV-2 Neutralizing Antibodies Detection Kit (P.1 Variant, Gamma)<\/strong><\/td>AG-48B-0004<\/a><\/td>To measure the presence of neutralising\/blocking antibodies in human serum\/plasma that inhibit the binding of the SARS-CoV-2 Spike (RBD) (P.1 Variant, Gamma) protein to its human receptor ACE2.<\/td><\/tr>
SARS-CoV-2 Neutralizing Antibodies Detection Kit (B.1.351 Variant, Beta)<\/strong><\/td>AG-48B-0005<\/a><\/td>To measure the presence of neutralising\/blocking antibodies in human serum\/plasma that inhibit the binding of the SARS-CoV-2 Spike (RBD) (B.1.351 Variant, Beta) protein to its human receptor ACE2.<\/td><\/tr>
SARS-CoV-2 Neutralizing Antibodies Detection Kit (B.1.617.1 Variant, Kappa)<\/strong><\/td>AG-48B-0006<\/a><\/td>To measure the presence of neutralising\/blocking antibodies in human serum\/plasma that inhibit the binding of the SARS-CoV-2 Spike (RBD) (B.1.617.1 Variant, Kappa) protein to its human receptor ACE2.<\/td><\/tr>
NEW<\/strong>
SARS-CoV-2 Neutralizing Antibodies Detection Kit (B.1.617.2 Variant, Delta)<\/strong><\/td>		AG-48B-0007<\/a><\/td>To measure the presence of neutralising\/blocking antibodies in human serum\/plasma that inhibit the binding of the SARS-CoV-2 Spike (RBD) (B.1.617.2 Variant, Delta) protein to its human receptor ACE2.<\/td><\/tr>
The STANDARD for Initial SARS-CoV-2 Strain
SARS-CoV-2 Neutralizing Antibodies Detection Kit<\/strong><\/td>		AG-48B-0002<\/a><\/td>To measure the presence of neutralising\/blocking antibodies in human serum\/plasma that inhibit the binding of the SARS-CoV-2 Spike (RBD) (initial strain) protein to its human receptor ACE2.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Originally posted on adipogen.com\/covid-19<\/a><\/p>\n\n\n\n

Caltag Medsystems <\/a>is the distributor of Adipogen<\/a> products in the UK and Ireland. If you have any questions about these products, please contact<\/a> us<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

List of AdipoGen Life Sciences’ neutralising antibody detection kits for SARS-CoV-2 variants<\/p>\n","protected":false},"author":13,"featured_media":7886,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[132,517],"tags":[279,185,515,673,518],"class_list":["post-7895","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-antibodies","category-covid-19","tag-adipogen","tag-antibodies","tag-covid-19","tag-detection-kit","tag-sars-cov-2"],"_links":{"self":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts\/7895","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/comments?post=7895"}],"version-history":[{"count":1,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts\/7895\/revisions"}],"predecessor-version":[{"id":7896,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts\/7895\/revisions\/7896"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/media\/7886"}],"wp:attachment":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/media?parent=7895"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/categories?post=7895"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/tags?post=7895"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}